Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.47 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.47 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.47 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.47 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.46 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.46 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.46 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.46 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.46 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | F2 | P00734 | 2/20 | 0.42 |
| ▸ | ELANE | P08246 | 2/20 | 0.42 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | CTSG | P08311 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25911018 | 1.00 | HTR2C (0.48) | HTR2CPDK1PDK2PDK3PDK4 | |
| SCHEMBL4693326 | 0.76 | HTR2C (0.52) | HTR2CPDK1PDK2PDK3PDK4 | |
| SCHEMBL5517082 | 0.75 | HTR2C (0.64) | HTR2CPDK1PDK2PDK3PDK4 | |
| SCHEMBL10053573 | 0.75 | HTR2C (0.64) | HTR2CPDK1PDK2PDK3PDK4 | |
| SCHEMBL5517077 | 0.75 | HTR2C (0.64) | HTR2CPDK1PDK2PDK3PDK4 | |
| SCHEMBL28956425 | 0.75 | PSEN1 (0.46) | HTR2CPDK1PDK2PDK3PDK4 | |
| SCHEMBL14209521 | 0.75 | HTR2C (0.57) | HTR2CPDK1PDK2PDK3PDK4 | |
| SCHEMBL31114244 | 0.75 | HTR2C (0.57) | HTR2CPDK1PDK2PDK3PDK4 | |
| SCHEMBL2249043 | 0.73 | HTR2C (0.52) | HTR2CPDK1PDK2PDK3PDK4 | |
| SCHEMBL21872248 | 0.73 | HTR2C (0.55) | HTR2CPSEN1PSEN2APH1BNCSTN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6117223-A | Hot melt inks containing polyketones | XEROX CORPORATION (US) | 2000-09-12 | — | — | US | claimed |
| EP-4219511-A1 | INTERMEDIATE, PREPARING METHOD THEREOF, AND METHOD OF PREPARING DRUG | Heron Neutron Medical Corp. (TW) | 2023-08-02 | — | — | EP | disclosed |
| US-20230234973-A1 | INTERMEDIATE, PREPARING METHOD THEREOF, AND METHOD OF PREPARING DRUG | HERON NEUTRON MEDICAL CORP. (TW) | 2023-07-27 | — | — | US | disclosed |
| US-6461417-B1 | Ink compositions | XEROX CORPORATION | 2002-10-08 | — | — | US | disclosed |
| US-6117223-A | Hot melt inks containing polyketones | XEROX CORPORATION (US) | 2000-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234973-A1 | INTERMEDIATE, PREPARING METHOD THEREOF, AND METHOD OF PREPARING DRUG | CYP2F1, SULT1A1, CYP4F3 | HTR2C 2536/4885PDK1 3737/4885PDK2 3567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.